Atlas Trials

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002

Clinical trial NCT02334436 · COMPLETED

Trial details

NCT number
NCT02334436
Sponsor
Evolus, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Glabellar Frown Lines
Start date
2015-01-01
Primary completion
2015-09-01
Enrollment
324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.